Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2003

01-07-2003 | Case Report

Fatal, gold-induced pneumonitis

Authors: M. Jose Soler, Encarnacion Barroso, F. Ignacio Aranda, Sergio Alonso, Santiago Romero

Published in: Rheumatology International | Issue 4/2003

Login to get access

Abstract

We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.
Literature
1.
Tomioka H, King TE Jr (1997) Gold-induced pulmonary disease: Clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 155:1011–1020PubMed
2.
Winterbauer RH, Wilske KR, Wheelis RF (1976) Diffuse pulmonary injury associated with gold treatment. N Engl J Med 294:919–921PubMed
3.
Shaban MR, Golding DN, Letcher RGM (1984) Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis. J R Soc Med 77:960–961PubMed
4.
McCormick J, Cole S, Lahirir B, Knauft F, Cohen S, Yoshida T (1980) Pneumonitis caused by gold salt therapy: evidence for the role of cell-mediated immunity in its pathogenesis. Am Rev Respir Dis 122:145–152PubMed
5.
Holness L, Tenenbaum J, Cooter NBE, Grossman RF (1983) Fatal bronchiolitis obliterans associated with chrysotherapy. Ann Rheum Dis 42:593–6PubMed
6.
Kollef MH, Irvine T, Cragun WH (1988) Nonbacterial thrombotic endocarditis associated with gold-induced pulmonary disease. Ann Intern Med 108:903–904
7.
Noseworthy TW, Davey RS, Percy JS, King EG (1983) Hypoxemic respiratory failure in rheumatoid arthritis. Gold related?. Crit Care Med 11:761–762PubMed
8.
Lertratanakul Y, Budiman-Mac E, Dietz AA, Jablokow VR, Rothfuss S, Schumacher HR (1986) Gold pneumonitis. A case report with electromicroscopic and electron probe analysis. Clin Exp Rheumatol 4:371–374PubMed
9.
Gould PW, McCormack PL, Palmer DG (1977) Pulmonary damage associated with sodium aurothiomalate therapy. J Rheumatol 4:252–260PubMed
10.
Davis P, Menard H, Thompson J, Harth M, Beaudet F (1985) One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. J Rheumatol 12:60–67PubMed
11.
Lorber A, Simon T, Leeb J, Peter A, Wilcox S (1978) Chrysotherapy: suppression of immunoglobulin synthesis. Arthritis Rheum 21:785–791PubMed
12.
Snowden N, Dietch DM, The LS, Hilton RC, Haeney MR (1996) Antibody deficiency associated with gold treatment: natural history and management in 22 patients. Ann Rheum Dis 55:616–621PubMed
13.
Lawson TM, Bevan M, Linton S, Williams BD (1998) Serious opportunistic infection associated with gold-induced panhypogammaglobulinaemia. Br J Rheumatol 37:914–916
14.
Morley TF, Komansky HJ, Adelizzi RA, Guidice JC (1984) Pulmonary gold toxicity. Eur J Respir Dis 65:627–632PubMed
15.
Slingerland R, Hoogsteden HC, Adriaansen HJ, van der Kwast TH, Hilvering C (1987) Gold-induced pneumonitis. Respiration 52:232–236PubMed
16.
Blancas R, Moreno JL, Martín F, de la Casa R, Oñoro JJ, Gómez V, Prados J (1998) Alveolar-interstitial pneumopathy after gold-salts compounds administration, requiring mechanical ventilation. Intensive Care Med 24:1110–1112CrossRefPubMed
Metadata
Title
Fatal, gold-induced pneumonitis
Authors
M. Jose Soler
Encarnacion Barroso
F. Ignacio Aranda
Sergio Alonso
Santiago Romero
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0293-4

Other articles of this Issue 4/2003

Rheumatology International 4/2003 Go to the issue

Original Article

Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan

Case Report

Unilateral phrenic nerve paralysis in a patient with Wegener's granulomatosis

Original Article

Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide

Case Report

Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis

Original Article

Joint pain and arthritis in renal transplant recipients and correlation with cyclosporine therapy

Case Report

Magnetic resonance imaging of peripheral osteoarticular tuberculosis compared with sonography and standard radiographs
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits